Editorial Review

Kidney International (1995) 48, 20–32; doi:10.1038/ki.1995.262

Glomerular actions of nitric oxide

Leopoldo Raij1 and Chris Baylis1

1Minneapolis, Minnesota and Morgantown, West Virginia, USA

Correspondence: Leopoldo Raij MD, Renal Section, VAMC, One Veterans Drive, Minneapolis, Minnesota 55417, USA.

Received 4 January 1994; Revised 29 August 1995; Accepted 29 August 1995.

Top

References

  1. Furchgott RF, Zawadzki JV: The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288:373–376, 1980 | Article | PubMed | ISI | ChemPort |
  2. Palmer RM, Ashton DS, Moncada S: Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 333:664–666, 1988 | Article | PubMed | ISI | ChemPort |
  3. Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G: Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 84:9265–9269, 1987 | Article | PubMed | ChemPort |
  4. Marletta MA, Yoon PS, Iyengar R, Leaf CD, Wishnok JS: Macrophage oxidation of L-arginine to nitrite and nitrate: Nitric oxide is an intermediate. Biochemistry 27:8706–8711, 1988 | Article | PubMed | ISI | ChemPort |
  5. Moncada S, Palmer RM, Higgs EA: Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev 43:109–142, 1991 | PubMed | ISI | ChemPort |
  6. Hibbs JB Jr, Vavrin Z, Taintor RR: L-arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells. J Immunol 138:550–565, 1987 | PubMed | ISI | ChemPort |
  7. Nathan C, Xie Q-W: Nitric oxide syntheses: Roles, tolls, and controls. Cell 78:915–918, 1994 | Article | PubMed | ISI | ChemPort |
  8. Garthwaite J, Charles SL, Chess-Williams R: Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature 336:385–388, 1988 | Article | PubMed | ISI | ChemPort |
  9. Griffith TM, Edwards DH, Davies RL, Harrison TJ, Evans KT: EDRF coordinates the behaviour of vascular resistance vessels. Nature 329:442–445, 1987 | Article |
  10. Raij L, Shultz PJ: Endothelium-derived relaxing factor, nitric oxide: Effects on and production by mesangial cells and the glomerulus. JASN 3:1435–1441, 1993
  11. Rees DD, Palmer RM, Moncada S: Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci USA 86:3375–3378, 1989 | Article | PubMed | ChemPort |
  12. Tolins JP, Palmer RM, Moncada S, Raij L: Role of endothelium-derived relaxing factor in regulation of renal hemodynamic responses. Am J Physiol 258:H655–H662, 1990 | PubMed | ISI | ChemPort |
  13. Bredt DS, Hwang PM, Glatt CE, Lowenstein C, Reed RR, Snyder SH: Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature 351:714–718, 1991 | Article | PubMed | ISI | ChemPort |
  14. Pollock JS, Forstermann U, Mitchell JA, Warner TD, Schmidt HH, Nakane M, Murad F: Purification and characterization of particulate endothelium-derived relaxing factor synthase from cultured and native bovine aortic endothelial cells. Proc Natl Acad Sci USA 88:10480–10484, 1991 | PubMed | ChemPort |
  15. Xie QW, Cho HJ, Calaycay J, Mumford RA, Swiderek KM, Lee TD, Ding A, Troso T, Nathan C: Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 256:225–228, 1992 | Article | PubMed | ISI | ChemPort |
  16. Bredt DS, Ferris CD, Snyder SH: Nitric oxide synthase regulatory sites. Phosphorylation by cyclic AMP-dependent protein kinase, protein kinase C, and calcium/calmodulin protein kinase; identification of flavin and calmodulin binding sites. J Biol Chem 267:10976–10981, 1992 | PubMed | ISI | ChemPort |
  17. Lamas S, Marsden PA, Ll GK, Tempst P, Michel T: Endothelial nitric oxide synthase: Molecular cloning and characterization of a distinct constitutive enzyme isoform. Proc Natl Acad Sci USA 89:6348–6352, 1992 | PubMed | ChemPort |
  18. Lyons CR, Orloff GJ, Cunningham JM: Molecular cloning and functional expression of an inducible nitric oxide synthase from a murine macrophage cell line. J Biol Chem 267:6370–6374, 1992 | PubMed | ISI | ChemPort |
  19. Stuehr DJ, Marletta MA: Mammalian nitrate biosynthesis: Mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide. Proc Natl Acad Sci USA 82:7738–7742, 1985 | PubMed | ChemPort |
  20. Stuehr DJ, Kwon NS, Nathan CF: FAD and GSH participate in macrophage synthesis of nitric oxide. Biochem Biophys Res Commun 168:558–565, 1990
  21. Wagner DA, Young VR, Tannenbaum SR: Mammalian nitrate biosynthesis: Incorporation of 15NH3 into nitrate is enhanced by endotoxin treatment. Proc Natl Acad Sci USA 80:4518–4521, 1983
  22. Evans T, Carpenter A, Cohen J: Purification of a distinctive form of endotoxin-induced nitric oxide synthase from rat liver. Proc Natl Acad Sci USA 89:5361–5365, 1992
  23. Geller DA, Lowenstein CJ, Shapiro RA, Nussler AK, Di-Silvio M, Wang SC, Nakayama DK, Simmons RL, Snyder SH, Rilliar TR: Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. Proc Natl Acad Sci USA 90:3491–3495, 1993 | Article | PubMed | ChemPort |
  24. Shultz PJ, Tayeh MA, Marletta MA, Raij L: Synthesis and action of nitric oxide in rat glomerular mesangial cells. Am J Physiol 261:F600–F606, 1991 | PubMed | ChemPort |
  25. Marsden PA, Ballermann BJ: Tumor necrosis factor alpha activates soluble guanylate cyclase in bovine glomerular mesangial cells via an L-arginine-dependent mechanism. J Exp Med 172:1843–1852, 1990 | PubMed |
  26. Pfeilschifter J, Rob P, Mulsch A, Fandrey J, Vosbeck K, Busse R: Interleukin 1beta and tumour necrosis factor alpha induce a macrophage-type of nitric oxide synthase in rat renal mesangial cells. Eur J Biochem 203:251–255, 1992 | Article | PubMed | ISI | ChemPort |
  27. Beasley D, Schwartz JH, Brenner BM: Interleukin 1 induces prolonged L-arginine-dependent cyclic guanosine monophosphate and nitrite production in rat vascular smooth muscle cells. J Clin Invest 87:602–608, 1991 | PubMed | ISI | ChemPort |
  28. Vanhoutte PM, Rubany GM, Miller VM, Houston DS: Modulation of vascular smooth muscle contraction by the endothelium. Ann Rev Physiol 48:307–320, 1986 | ChemPort |
  29. Nishida K, Harrison DG, Navas JP, Fisher AA, Dockery SP, Uematsu M, Nerem RM, Alexander RW, Murphy TJ: Molecular cloning and characterization of the constitutive bovine aortic endothelial cell nitric oxide synthase. J Clin Invest 90:2092–2096, 1992 | PubMed | ChemPort |
  30. Knowles RG, Moncada S: Nitric oxide synthases in mammals. Biochem J 298:249–258, 1994 | PubMed | ISI | ChemPort |
  31. Sessa WC: The nitric oxide synthase family of proteins. J Vase Res 31:131–143, 1994
  32. Ignarro LJ: Biosynthesis and metabolism of endothelium-derived nitric oxide. Annu Rev Pharmacol Toxicol 30:535–560, 1990 | Article | PubMed | ChemPort |
  33. Gross SS, Stuehr DJ, Aisaka K, Jaffe EA, Levi R, Griffith OW: Macrophage and endothelial cell nitric oxide synthesis: Cell-type selective inhibition by NG-aminoarginine, NG-nitroarginine and NG-methylarginine. Biochem Biophys Res Commun 170:96–103, 1990 | Article | PubMed | ISI | ChemPort |
  34. Ding A, Nathan CF, Graycar J, Derynck R, Stuehr DJ, Srimal S: Macrophage deactivating factor and transforming growth factors -beta1, beta2, and -beta3 inhibit induction of macrophage nitrogen oxide synthesis by IFN-gamma. J Immunol 145:940–944, 1990 | PubMed | ISI | ChemPort |
  35. Pfeilschifter J, Vosbeck K: Transforming growth factor beta2 inhibits interleukin 1beta- and tumor necrosis factor alpha-induction of nitric oxide synthase in rat renal mesangial cells. Biochem Biophys Res Commun 175:372–379, 1991 | Article | PubMed | ISI | ChemPort |
  36. Oswald IP, Gazzinelli RT, Sher A, James SL: 1L-10 synergizes with IL-4 and transforming growth factor-beta to inhibit macrophage cytotoxic activity. J Immunol 148:3578–3582, 1992 | PubMed | ISI | ChemPort |
  37. Cunha FQ, Moncada S, Liew FY: Interleukin-10 (IL-10) inhibits the induction of nitric oxide synthase by interferon-gamma in murine macrophages. Biochem Biophys Res Commun 182:1155–1159, 1992 | Article | PubMed | ISI | ChemPort |
  38. De Maria R, Cifone MG, Trotta R, Rippo MR, Festuccia C, Santoni A, Testi R: Triggering of human monocyte activation through CD69, a member of the natural killer cell gene complex family of signal transducing receptors. J Exp Med 180:1999–2004, 1994 | Article | PubMed | ChemPort |
  39. Bolotina VM, Najibi S, Palacino JJ, Pagano PJ, Cohen RA: Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature 368:850–853, 1994 | Article | PubMed | ISI | ChemPort |
  40. Lander HM, Sehajpal PK, Novogrodsky A: Nitric oxide signaling: A possible role for G proteins. J Immunol 151:7182–7187, 1993
  41. Radomski MW, Palmer RM, Moncada S: The anti-aggregating properties of vascular endothelium: Interactions between prostacyclin and nitric oxide. Br J Pharmacol 92:639–646, 1987 | PubMed | ISI | ChemPort |
  42. Mellion BT, Ignarro LJ, Ohlstein EH, Pontecorvo EG, Hyman AL, Kadowitz PJ: Evidence of the inhibitory role of guanosine 3', 5'-monophosphate in ADP-induced human platelet aggregation in the presence of nitric oxide and related vasodilators. Blood 57:946–955, 1981 | PubMed | ISI | ChemPort |
  43. Nathan CF, Hibbs JB Jr: Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr Opin Immunol 3:65–70, 1991 | Article | PubMed | ISI | ChemPort |
  44. Dimmeler S, Lottspeich F, Brune B: Nitric oxide causes ADP-ribosylation and inhibition of glyceraldehyde-3-phosphate dehydrogenase. J Biol Chem 267:16771–16774, 1992 | PubMed | ChemPort |
  45. Stamler JS, Singel DJ, Loscalzo J: Biochemistry of nitric oxide and its redox-activated forms. Science 258:1898–1902, 1992 | Article | PubMed | ISI | ChemPort |
  46. Nathan C: Nitric oxide and biopterin: A study in chiaroscuro. J Clin Invest 93:1875–1876, 1994
  47. Rosenkranz-Weiss P, Sessa WC, Milstien S, Kaufman S, Watson CA, Pober JS: Regulation of nitric oxide synthesis by proinflammatory cytokines in human umbilical vein endothelial cells. J Clin Invest 93:2236–2243, 1994 | PubMed | ChemPort |
  48. Mundel P, Bachmann S, Bader M, Fischer A, Kummer W, Mayer B, Kriz W: Expression of nitric oxide synthase in kidney macula densa cells. Kidney Int 42:1017–1019, 1992 | PubMed | ISI | ChemPort |
  49. Terada Y, Tomita K, Nonoguchi H, Marumo F: Polymerase chain reaction localization of constitutive nitric oxide synthase and soluble guanylate cyclase messenger RNAs in microdissected rat nephron segments. J Clin Invest 90:659–665, 1992 | PubMed | ISI | ChemPort |
  50. Ujiie K, Yuen J, Hograth L, Danziger R, Star RA: Localization and regulation of endothelial NO synthase mRNA expression in rat kidney. Am J Physiol 267 (Renal Fluid Electrol Physiol 36):F296–F302, 1994 | PubMed | ISI | ChemPort |
  51. Markewitz BA, Michael JR, Kohan DE: Cytokine-induced expression of a nitric oxide synthase in rat renal tubule cells. J Clin Invest 91:2138–2143, 1993 | PubMed | ISI | ChemPort |
  52. Baylis C: Glomerular filtration dynamics (Chapt 2), in Advances in Renal Physiology, edited by CJ Lote, London, Grune and Stratton, 1986, pp 33–83
  53. Dworkin LD, Brenner BM: Biophysical basis of glomerular filtration (Chapt 29), in The Kidney: Physiology and Pathophysiology (2nd ed), edited by DW Seldin, G Giebisch, New York, Raven Press, 1992, pp 979–1016
  54. Latta H, Maunschbach AB, Madden SC: The centralobular region of the renal glomerulaus studied by electron microscopy. J Ultrastmct Res 4:455–472, 1960
  55. Raij L, Keane WF: Glomerular mesangium: Its function and relationship to angiotensin II. Am J Med 79:24–30, 1985 | Article | PubMed | ISI | ChemPort |
  56. Michael AF, Keane WF, Raij L, Vernier RL, Mauer SM: The glomerular mesangium. Kidney Int 17:141–154, 1980 | PubMed | ISI | ChemPort |
  57. Sweeney C, Shultz P, Raij L: Interactions of the endothelium and mesangium in glomerular injury. JASN 1:S13–S20, 1990
  58. Pfeilschifter J: Cross-talk between transmembrane signalling systems: A prerequisite for the delicate regulation of glomerular haemodynamics by mesangial cells. Eur J Clin Invest 19:347–361, 1989 | PubMed | ISI | ChemPort |
  59. Mene P, Simonson MS, Dunn MJ: Physiology of the mesangial cell. Physiol Rev 69:1347–1424, 1989 | PubMed | ISI | ChemPort |
  60. Shultz PJ, Schorer AE, Raij L: Effects of endothelium-derived relaxing factor and nitric oxide on rat mesangial cells. Am J Physiol 258:F162–F167, 1990 | PubMed | ISI | ChemPort |
  61. Marsden PA, Brock TA, Ballermann BJ: Glomerular endothelial cells respond to calcium-mobilizing agonists with release of EDRF. Am J Physiol 258:F1295–F1303, 1990 | PubMed | ISI | ChemPort |
  62. Baylis C, Harton P, Engels K: Endothelial derived relaxing factor controls renal hemodynamics in the normal rat kidney. JASN 1:875–881, 1990
  63. Gardiner SM, Compton AM, Bennett T, Palmer RM, Moncada S: Control of regional blood flow by endothelium-derived nitric oxide. Hypertension 15:486–492, 1990 | PubMed | ISI | ChemPort |
  64. Lahera V, Salom MG, Miranda-Guardiola F, Moncada S, Romero JC: Effects of NG-nitro-L-arginine methyl ester on renal function and blood pressure. Am J Physiol 261:F1033–F1037, 1991 | PubMed | ISI | ChemPort |
  65. Granger JP, Alberola AM, Salazar FJ, Nakamura T: Control of renal hemodynamics during intrarenal and systemic blockade of nitric oxide synthesis in conscious dogs. J Cardiovas Pharmacol 20:S160–S162, 1992 | ChemPort |
  66. Elsner D, Muntze A, Kromer EP, Riegger GA: Inhibition of synthesis of endothelium-derived nitric oxide in conscious dogs. Hemodynamic, renal, and hormone effects. Am J Hypertens 5:288–291, 1992 | PubMed | ChemPort |
  67. Perrella MA, Hildebrand FL Jr, Margulies KB, Burnett JC Jr: Endothelium-derived relaxing factor in regulation of basal cardiopulmonary and renal function. Am J Physiol 261:R323–R328, 1991
  68. Yukimura T, Yamashita Y, Miura K, Okumura M, Yamanaka S, Yamamoto K: Renal effects of the nitric oxide synthase inhibitor, L-NG-nitroarginine, in dogs. Am J Hypertens 5:484–487, 1992
  69. RaderMacHer J, Klanke B, Kastner S, Haake G, Schurek H-J, Stolte HF, Frolich JC: Effects of arginine depletion on glomerular and tubular kidney function: Studies in isolated perfused rat kidneys. Am J Physiol 261:F779–F786, 1991 | PubMed |
  70. Siragy HM, Johns RA, Peach MJ, Carey RM: Nitrix oxide alters renal function and guanosine 3',5'-cyclic monophosphate. Hypertension 19:775–779, 1992 | PubMed | ISI | ChemPort |
  71. Welch WJ, Wilcox CS, Aisaka K, Cross SS, Griffith OW, Fontoura BMA, Maack T, Levi R: Nitric oxide synthesis from L-arginine modulates renal vascular resistance in isolated perfused and intact rat kidneys. J Cardiovas Pharmacol 17:S165–S168, 1991
  72. Naess PA, Kirkeboen KA, Christensen G, Kiil F: Inhibition of renal nitric oxide synthesis with NG-monomethyl-L-arginine and NG-nitro-L-arginine. Am J Physiol 262:F939–F942, 1992
  73. Walder CE, Thiemermann C, Vane JR: The involvement of endothelium-deprived relaxing factor in the regulation of renal cortical blood flow in the rat. Br J Pharmacol 102:967–973, 1991 | PubMed | ISI | ChemPort |
  74. Slangen B, Weaver C, Baylis C: Renal effects of low dose nitric oxide (NO) inhibition in the rat. (abstract) JASN 4:569A, 1993
  75. Zatz R, De Nucci G: Effects of acute nitric oxide inhibition on rat glomerular microcirculation. Am J Physiol 261:F360–F363, 1991 | PubMed |
  76. Deng A, Baylis C: Locally produced EDRF control preglomerular resistance and ultrafiltration coefficient. Am J Physiol 264:F212–F215, 1993 | PubMed | ISI | ChemPort |
  77. Appel RG, Wang J, Simonson MS, Dunn MJ: A mechanism by which atrial natriuretic factor mediates its glomerular actions. Am J Physiol 251:F1036–F1042, 1986 | PubMed | ChemPort |
  78. Navar LG: Renal autoregulation: Perspectives from whole kidney and single nephron studies. Am J Physiol 234:F357–F370, 1978 | PubMed | ISI | ChemPort |
  79. Ito S, Johnson CS, Carretero OA: Modulation of angiotensin II-induced vasoconstriction by endothelium-derived relaxing factor in the isolated microperfused rabbit afferent arteriole. J Clin Invest 87:1656–1663, 1991 | PubMed | ISI | ChemPort |
  80. Ito S, Arima S, Ren YL, Juncos LA, Carretero OA: Endothelium-derived relaxing factor/nitric oxide modulates angiotensin II action in the isolated microperfused rabbit afferent but not efferent arteriole. J Clin Invest 91:2012–2019, 1993 | PubMed | ISI | ChemPort |
  81. Edwards RM, Trizna W: Modulation of glomerular arteriolar tone by nitric oxide synthase inhibitors. JASN (in press)
  82. Ohishi K, Carmines PK, Inscho EW, Navar LG: EDRF-angioten-sin II interactions in rat juxtamedullary afferent and efferent arterioles. Am J Physiol 263:F900–F906, 1992 | PubMed | ChemPort |
  83. Gabbai FB, Peterson DW, Khang S, Blantz RC: Glomerular hemodynamics in the isolated perfused rat kidney in control and during administration of NG-monomethyl L-arginine. (abstract) JASN 3:561A, 1992
  84. He X-R, Greenberg SG, Schnermann J, Briggs JP: The effect of NO on renin release from rabbit isolated perfused juxtaglomerular apparatus. (abstract) JASN 3:545A, 1992
  85. He X-R, Greenberg SG, Schnermann JB, Briggs JP: Role of nitric oxide (NO) in regulation of macula densa mediated renin secretion. (abstract) FASEB J 7:1267A, 1993
  86. Wilcox CS, Welch WJ, Murad F, Gross SS, Taylor G, Levi R, Schmidt HH: Nitric oxide synthase in macula densa regulates glomerular capillary pressure. Proc Natl Acad Sci USA 89:11993–11997, 1992 | PubMed | ChemPort |
  87. Ito S, Ren Y: Evidence for the role of nitric oxide in macula densa control of glomerular hemodynamics. J Clin Invest 92:1093–1098, 1993 | PubMed | ISI | ChemPort |
  88. Bachmann S, Bosse H-M, Mundel P: Regulation of nitric oxyde synthase (NOS) in rat kidney macula densa cells. (abstract) JASN 4:545A, 1993
  89. Arnal JF, Warin L, Michel JB: Determinants of aortic cyclic guanosine monophosphate in hypertension induced by chronic inhibition of nitric oxide synthase. J Clin Invest 90:647–652, 1992 | PubMed | ISI | ChemPort |
  90. Baylis C, Mitruka B, Deng A: Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage. J Clin Invest 90:278–281, 1992 | PubMed | ISI | ChemPort |
  91. Ribeiro MO, Antunes E, De Nucci G, Lovisolo SM, Zatz R: Chronic inhibition of nitric oxide synthesis. A new model of arterial hypertension. Hypertension 20:298–303, 1992 | PubMed | ISI | ChemPort |
  92. Deng A, Samsell L, Baylis C: Glomerular hemodynamic effects of fenoldapam (F) in 5/6th renal ablation (ABL) and chronic nitric oxide blockade (NOB) induced systemic and glomerular hypertension. JASN (in press)
  93. Qiu CB, Engels K, Baylis C: Evolution of chronic endothelial derived relaxing factor (EDRF) blockade induced hypertension (EB-HT). (abstract) JASN 3:550A, 1992
  94. Dananberg J, Sider RS, Grekin RJ: Sustained hypertension induced by orally administered nitro-L-arginine. Hypertension 21:359–363, 1993
  95. Salazar FJ, Pinilla JM, Lopez F, Romero JC, Quesada T: Renal effects of prolonged synthesis inhibition of endothelium-derived nitric oxide. Hypertension 20:113–117, 1992 | PubMed | ISI | ChemPort |
  96. Kumagai K, Suzuki H, Ichikawa M, Jimbo M, Murakami M, Ryuzaki M, Saruta T: Nitric oxide increases renal blood flow by interacting with the sympathetic nervous system. Hypertension 24:220–226, 1994
  97. Gardiner SM, Kemp PA, Bennett T: Effects of chronic treatment with nitric oxide synthase inhibitors on regional haemodynamic responses to vasodilators in conscious Brattleboro rats. Br J Pharmacol 109:222–228, 1993 | PubMed | ChemPort |
  98. Griffith TM, Edwards DH: Myogenic autoregulation of flow may be inversely related to endothelium-derived relaxing factor activity. (published erratum appears in Am J Physiol p 259, Dec 1990 following Table of Contents) Am J Physiol 258:H1171–H1180, 1990
  99. Baumann JE, Persson PB, Ehmke H, Nafz B, Kirchheim HR: Role of endothelium-derived relaxing factor in renal autoregulation in conscious dogs. Am J Physiol 263:F208–F213, 1992
  100. Beierwaltes WH, Sigmon DH, Carretero OA: Endothelium modulates renal blood flow but not autoregulation. Am J Physiol 262:F943–F949, 1992 | PubMed | ChemPort |
  101. Majid DS, Navar LG: Suppression of blood flow autoregulation plateau during nitric oxide blockade in canine kidney. Am J Physiol 262:F40–F46, 1992
  102. Salom MG, LaHera V, Miranda-Guardiola F, Romero JC: Blockade of pressure natriuresis induced by inhibition of renal synthesis of nitric oxide in dogs. Am J Physiol 262:F718–F722, 1992 | PubMed |
  103. Schultz MF, Robinette JB, Conger JD: Nitric oxide is a factor in the lower range of renal autoregulation in the rat. (abstract) JASN 3:551A, 1992
  104. Baylis C, Deen WM, Myers BD, Brenner BM: Effects of some vasodilator drugs on transcapillary fluid exchange in renal cortex. Am J Physiol 230:1148–1158, 1976 | PubMed | ISI | ChemPort |
  105. Ito S, Carretero OA: Impaired response to acetylcholine despite intact endothelium-derived relaxing factor/nitric oxide in isolated microperfused afferent arterioles of the spontaneously hypertensive rat. J Cardiovasc Pharmacol 20(Suppl 12):S187–S189, 1992 | PubMed | ISI | ChemPort |
  106. Edwards RM: Response of isolated renal arterioles to acetylcholine, dopamine, and bradykinin. Am J Physiol 248:F183–F189, 1985 | PubMed | ISI | ChemPort |
  107. Kon V, Harris RC, Ichikawa I: A regulatory role for large vessels in organ circulation. Endothelial cells of the main renal artery modulate intrarenal hemodynamics in the rat. J Clin Invest 85:1728–1733, 1990
  108. Bascands JL, Emond C, Pecher C, Regoli D, Girolami JP: Bradykinin stimulates production of inositol (1,4,5) trisphosphate in cultured mesangial cells of the rat via a BK2-kinin receptor. Br J Pharmacol 102:962–966, 1991
  109. Kremer S, Harper P, Hegele R, Skorecki K: Bradykinin stimulates a rise in cytosolic calcium in renal glomerular mesangial cells via a pertussis toxin insensitive pathway. Can J Physiol Pharmacol 66:43–48, 1988 | PubMed | ISI | ChemPort |
  110. Cachofeiro V, Nasjletti A: Increased vascular responsiveness to bradykinin in kidneys of spontaneously hypertensive rats. Effect of N-nitro-L-arginine. Hypertension 18:683–688, 1991 | PubMed |
  111. Fulton D, McGiff JC, Quilley J: Contribution of NO and cytochrome P450 to the vasodilator effect of bradykinin in the rat kidney. Br J Pharmacol 107:722–725, 1992 | PubMed | ISI | ChemPort |
  112. Lahera V, Salom MG, Fiksen-Olsen MJ, Raij L, Romero JC: Effects of NG-monomethyl-L-arginine and L-arginine on acetylcholine renal response. Hypertension 15:659–663, 1990 | PubMed | ISI | ChemPort |
  113. Lahera V, Salom MG, Fiksen-Olsen MJ, Romero JC: Mediatory role of endothelium-derived nitric oxide in renal vasodilatory and excretory effects of bradykinin. Am J Hypertens 4:260–262, 1991 | PubMed | ISI | ChemPort |
  114. Hostetter TH: Human renal response to a meat meal. Am J Physiol 250:F613–F618, 1986 | PubMed | ISI | ChemPort |
  115. Tolins JP, Raij L: Effects of amino acid infusion on renal hemodynamics. Role of endothelium-derived relaxing factor. Hypertension 17:1045–1051, 1991
  116. King AJ, Troy JL, Anderson S, Neuringer JR, Gunning M, Brenner BM: Nitric oxide: A potential mediator of amino acid induced renal hyperemia and hyperfiltration. JASN 1:1271–1277, 1991
  117. Chen C, Mitchell KD, Navar LG: Role of endothelium-derived nitric oxide in the renal hemodynamic response to amino acid infusion. Am J Physiol 263:R510–R516, 1992
  118. Vargas HM, Ignarro LJ, Chaudhuri G: Physiological release of nitric oxide is dependent on the level of vascular tone. J Pharmacol 190:393–397, 1990
  119. Sigmon DH, Carretero OA, Beierwaltes WH: Angiotensin dependence of endothelium-mediated renal hemodynamics. Hypertension 20:F643–F650, 1992
  120. Baylis C, Engels K, Samsell L, Harton P: Renal effects of acute endothelial derived relaxing factor blockade are not mediated by angiotensin II. Am J Physiol 264:F74–F78, 1993 | PubMed | ChemPort |
  121. Pucci ML, Lin L, Nasjletti A: Pressor and renal vasoconstrictor effects of NG-nitro-L-arginine as affected by blockade of pressor mechanisms mediated by the sympathetic nervous system, angiotensin, prostanoids and vasopressin. J Pharmacol Exp Ther 261:240–245, 1992 | PubMed | ISI | ChemPort |
  122. Sigmon DH, Beierwaltes WH: Angiotensin II: nitric oxide interaction and the distribution of blood flow. Am J Physiol 265:R1276–R1283, 1993 | PubMed | ISI | ChemPort |
  123. Falk SA, Conger JD: Effect of losartan on constrictor responses to L-NAME in isolated rat renal arterioles. (abstract) JASN 4:548, 1993
  124. De Nicola L, Blantz RC, Gabbai FB: Nitric oxide and angiotensin II. Glomerular and tubular interaction in the rat. J Clin Invest 89:1248–1256, 1992 | PubMed | ISI | ChemPort |
  125. Alberola A, Salazar FJ, Nakamura T, Granger JP: Renal hemodynamic effects of angiotensin II (All): Interactions with endothelium derived nitric oxide. (abstract) FASEB J 6:A 1812, 1992
  126. Baylis C, Harvey J, Engels K: Nitric oxide (NO) synthesis inhibition selectively potentiates the renal vasoconstrictor response to angiotensin II (All). Proc Aust NZ Soc Nephrol 1993; Kidney Int (in press)
  127. Sigmon DH, Beierwaltes WH: Renal nitric oxide and angiotensin II interaction in renovascular hypertension. Hypertension 22:237–242, 1993 | PubMed |
  128. Manning RD Jr, Hu L, Mizelle HL, Granger JP: Role of nitric oxide in long-term angiotensin II-induced renal vasoconstriction. Hypertension 21:949–955, 1993
  129. Pollock DM, Polakowski JS, Divish BJ, Opgenorth TJ: Angiotensin blockade reverses hypertension during long-term nitric oxide synthase inhibition. Hypertension 21:660–666, 1993 | PubMed | ISI | ChemPort |
  130. Qiu C, Engels K, Baylis C: Importance of angiotensin II and alpha1-adrenergic tone in chronic nitric oxide blockade-induced hypertension in conscious rats. Am J Physiol (in press)
  131. Gardes J, Poux JM, Gonzales MF, Alhenc-Gelas F, Menard J: Decreased renin release and constant kallikrein secretion after injection of L-NAME in isolated perfused rat kidney. Life Sci 50:987–993, 1992
  132. Johnson RA, Freeman RH: Pressure natriuresis in rats during blockade of the L-arginine/nitric oxide pathway. Hypertension 19:333–338, 1992 | PubMed |
  133. Kurtz A, Kaissling B, Busse R, Baier W: Endothelial cells modulate renin secretion from isolated mouse juxtaglomerular cells. J Clin Invest 88:1147–1154, 1991 | PubMed |
  134. Beierwaltes WH, Carretero OA: Nonprostanoid endothelium-derived factors inhibit renin release. Hypertension 19(Suppl 2):1168–1173, 1992
  135. Sigmon DH, Carretero OA, Beierwaltes WH: Endothelium-derived relaxing factor regulates renin release in vivo. Am J Physiol 263:F256–F261, 1992 | PubMed |
  136. Vidal MJ, Romero JC, Vanhoutte PM: Endothelium-derived relaxing factor inhibits renin release. Eur J Pharmacol 149:401–402, 1988
  137. Pegoraro AA, Carretero OA, Sigmon DH, Beierwaltes WH: Sympathetic modulation of endothelium-derived relaxing factor. Hypertension 19:643–647, 1992
  138. Lacolley PJ, Lewis SJ, Brody MJ: Role of sympathetic nerve activity in the generation of vascular nitric oxide in urethane-anesthetized rats. Hypertension 17:881–887, 1991 | PubMed | ISI | ChemPort |
  139. Nakashima A, Matsuoka H, Nishida H, Nomura G, Morimatsu M: Intraglomerular platelet aggregation by chronic inhibition of nitric oxide synthesis. (abstract) JASN 4:561, 1993
  140. Pollock DM, Opgenorth TJ: Evidence for endothelin-induced renal vasoconstriction independent of ETA receptor activation. Am J Physiol 264:R222–R226, 1993 | PubMed | ISI | ChemPort |
  141. Hagiwara H, Nagasawa T, Yamamoto T, Lodhi KM, Ito T, Takemura N, Hirose S: Immunochemical characterization and localization of endothelin ETB receptor. Am J Physiol 264:R777–R783, 1993
  142. Madeddu P, Anania V, Parpaglia PP, Troffa C, Pazzola A, Soro A, Manunta P, Tonolo G, Demontis MP, Varoni MV, Melis MG, Glorioso N: Endothelin-1-induced renal vasoconstriction is blunted by enalaprilat and enhanced by EDRF antagonist in awake normotensive rats. Clin Invest Med 14:600–606, 1991
  143. Hirata Y, Matsuoka H, Kimura K, Sugimoto T, Hayakawa H, Suzuki E, Sugimoto T: Role of endothelium-derived relaxing factor in endothelin-induced renal vasoconstriction. J Cardiovas Pharmacol 17(Suppl):S169–S171, 1991
  144. Rogerson ME, Cairns HS, Fairbanks LD, Westwick J, Neild GH: Endothelin-1 in the rabbit: Interactions with cyclo-oxygenase and NO-synthase products. Br J Pharmacol Mar 108:838–843, 1993
  145. Lerman A, Sandok EK, Hildebrand FL Jr, Burnett JC Jr: Inhibition of endothelium-derived relaxing factor enhances endothelin-mediated vasoconstriction. Circulation 85:1894–1898, 1992 | PubMed | ChemPort |
  146. Ito S, Juncos LA, Nushiro N, Johnson CS, Carretero OA: Endothelium-derived relaxing factor modulates endothelin action in afferent arterioles. Hypertension 17:1052–1056, 1991 | PubMed | ISI | ChemPort |
  147. Juncos LA, Ren YL, Arima S, Ito S: Vasodilator and constrictor actions of platelet-activating factor in the isolated microperfused afferent arteriole of the rabbit kidney. Role of endothelium-derived relaxing factor/nitric oxide and cyclooxygenase products. J Clin Invest 91:1374–1379, 1993 | PubMed | ISI | ChemPort |
  148. Arima S, Ren Y, Juncos LA, Ito S: Platelet-activating factor (PAF) dilates efferent arterioles (Ef-Arts) through glomerulus (GL)-de-rived nitric oxide (NO). (abstract) JASN 4:544, 1993
  149. Vanhoutte PM, Rubanyl GM, Miller VM, Houston DS: Modulation of vascular smooth muscle contraction by the endothelium. Annu Rev Physiol 48:307–320, 1986 | Article | PubMed | ISI | ChemPort |
  150. Doni MG, Whittle BJR, Palmer RM, Moncada S: Actions of nitric oxide on the release of prostacyclin from bovine endothelial cells in culture. Eur J Pharmacol 151:19–25, 1988 | Article | PubMed | ChemPort |
  151. Marotta P, Sautebin L, Di Rose M: Modulation of the induction of nitric oxide synthase by eicosanoids in the murine macrophage cell line J774. Br J Pharmacol 107:640–641, 1992 | PubMed | ISI | ChemPort |
  152. Luckhoff A, Mulsch A, Busse R. cAMP attenuates autacoid release from endothelial cells: Relation to internal calcium. Am J Physiol 258:H960–H966, 1990
  153. Gaillard T, Mulsch A, Klein H, Decker K: Regulation by prostaglandin E2 of cytokine-elicited nitric oxide synthesis in rat liver macrophages. Biol Chem Hoppe-Seyler 373:897–902, 1992
  154. Salvemini D, Misko TP, Masferrer JL, Seibert K, Currie MG, Needleman P: Nitric oxide activates cyclooxygenase enzymes. Proc Natl Acad Sci USA 90:7240–7244, 1993 | Article | PubMed | ChemPort |
  155. Weaver C, Engels K, Baylis C: No interaction between endothelial cyclooxygenase products and endothelial derived relaxing factor (EDRF) in chronic EDRF blockade induced hypertension (EB-HT). (abstract) JASN 3:528, 1992
  156. Shultz PJ, Tolins JP: Adaptation to increased dietary salt intake in the rat. Role of endogenous nitric oxide. J Clin Invest 91:642–650, 1993 | PubMed | ISI | ChemPort |
  157. Chen PY, Sanders PW: L-arginine abrogates salt-sensitive hypertension in Dahl/Rapp rats. J Clin Invest 88:1559–1567, 1991 | PubMed | ISI | ChemPort |
  158. Salazar FJ, Alberola A, Pinilla JM, Romero JC, Quesada T: Salt-induced increase in arterial pressure during nitric oxide synthesis inhibition. Hypertension 22:49–55, 1993 | PubMed |
  159. Tolins JP, Shultz PJ: Endogenous nitric oxide synthesis determines sensitivity to the pressor effect of salt. Kidney Int 46:230–236, 1994 | PubMed | ISI | ChemPort |
  160. Jover B, Herizi A, Ventre F, Dupont M, Mimran A: Sodium and angiotensin in hypertension induced by long-term nitric oxide blockade. Hypertension 21:944–948, 1993 | PubMed | ISI | ChemPort |
  161. Campese VM, Raij L: Effect of varied salt intakes on serum levels of nitric oxide (NO) in human essential hypertension (EH). (abstract) JASN 5:558, 1994
  162. Ortenberg JM, Cook AK, Inscho EW, Carmines PK: Attenuated afferent arteriolar response to acetylcholine in Goldblatt hypertension. Hypertension 19:785–789, 1992
  163. Weisstuch JM, Stein S, Dworkin LD: Blockade of endothelial derived relaxing factor (EDRF) synthesis reverses the increase in renal plasma flow (RPF) that follows unilateral nephrectomy (UNX). (abstract) JASN 2:514, 1991
  164. Reyes AA, Purkerson ML, Karl I, Klahr S: Dietary supplementation with L-arginine ameliorates the progression of renal disease in rats with subtotal nephrectomy. Am J Kid Dis 20:168–176, 1992
  165. Hayakawa H, Hirata Y, Suzuki E, Sugimoto T, Matsuoka H, Kikuchi K, Nagano T, Hirobe M, Sugimoto T: Mechanisms for altered endothelium-dependent vasorelaxation in isolated kidneys from experimental hypertensive rats. Am J Physiol 264:H1535–H1541, 1993 | PubMed | ChemPort |
  166. Luscher TF, Raij L, Vanhoutte PM: Endothelium-dependent vascular responses in normotensive and hypertensive Dahl-rats. Hypertension 9:157–163, 1987 | PubMed | ISI | ChemPort |
  167. Conger JD, Robinette JB, Schrier RW: Smooth muscle calcium and endothelium-derived relaxing factor in the abnormal vascular responses of acute renal failure. J Clin Invest 82:532–537, 1988 | PubMed | ISI | ChemPort |
  168. Robinette JB, Conger JD: Nitric oxide synthase (NOS) activity is increased not decreased - in vasculature of acute renal failure (ARF) kidneys. (abstract) JASN 4:743, 1993
  169. Rivas-Cabanero L, Montero A, Lopez-Novoa JM: Nitric oxide synthesis is increased in rats with gentamicin-induced renal failure. (abstract) XII Int Cong Nephrol, 1993, p 571
  170. Maree A, Peer G, Schwartz D, Serban I, Blum M, Cabili S, Iaina A: Endothelial derived relaxation factor (EDRF) in glycerol (G) acute renal failure (ARF) in rats. (abstract) XII Intl Congr Nephrol, 1993, p 283
  171. Schramm L, Lopau K, Schaar J, Gotz R, Heidbreder E, Heidland A: Beneficial effects of L-arginine (ARG) and methyl-L-arginine (MeARG) on renal function in toxic acute renal failure (ARF) in the rat. (abstract) JASN 4:744, 1993
  172. De Nicola L, Thomson SC, Wead LM, Brown MR, Gabbai FB: Arginine feeding modifies cyclosporine nephrotoxicity in rats. J Clin Invest 92:1859–1865, 1993 | PubMed | ISI | ChemPort |
  173. Hostetter TH, Troy JL, Brenner BM: Glomerular hemodynamics in experimental diabetes mellitus. Kidney Int 19:410–415, 1981 | PubMed | ISI | ChemPort |
  174. King AJ, Zayas MA, Troy JL, Downes SJ, Brenner BM: Inhibition of diabetes-induced hyperfiltration and hyperemia by Nw-monomethyl-L-arginine. (abstract) JASN 1:666, 1990
  175. Tolins JP, Shultz PJ, Raij L, Brown DM, Mauer SM: Abnormal renal hemodynamic response to reduced renal perfusion pressure in diabetic rats: Role of NO. Am J Physiol 265:F886–895, 1993 | PubMed | ISI | ChemPort |
  176. Bank N, Aynedjian HS: Role of EDRF (nitric oxide) in diabetic renal hyperfiltration. Kidney Int 43:1306–1312, 1993 | PubMed | ISI | ChemPort |
  177. Bucala R, Tracey KJ, Cerami A: Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilation in experimental diabetes. J Clin Invest 87:432–438, 1991 | PubMed | ISI | ChemPort |
  178. Derubertis FR, Craven PA: Activation of protein kinase C in glomerular cells in diabetes. Diabetes 43:1–8, 1994 | PubMed | ISI | ChemPort |
  179. Shultz PJ, Raij L: Endogenously synthesized nitric oxide prevents endotoxin-induced glomerular thrombosis. J Clin Invest 90:1718–1725, 1992 | PubMed | ISI | ChemPort |
  180. Wilson CB: The renal response to immunologic injury, in The Kidney (chapt 25, 4th ed), edited by B Brenner, F Rector, New York, W.B. Saunders Company, 1991, pp 1062–1181
  181. Raij L: Glomerular thrombosis in pregnancy: Role of L-arginine and nitric oxide pathway. Kidney Int 45:775–781, 1994 | PubMed | ISI |
  182. Bone RC: The pathogenesis of sepsis. Ann Intern Med 115:457–469, 1991 | PubMed | ISI | ChemPort |
  183. Kilbourn RG, Gross SS, Jubran A, Adams J, Griffith OW, Levi R, Lodato RF: Ng-Methyl-L-arginine inhibits tumor necrosis factor induced hypotension: Implications for the involvement of nitric oxide. Proc Natl Acad Sci USA 87:3629–3632, 1990 | Article | PubMed | ChemPort |
  184. Westberg G, Shultz PJ, Raij L: Exogenous nitric oxide prevents endotoxin-induced renal glomerular thrombosis in rats. Kidney Int 46:711–716, 1994 | PubMed | ISI | ChemPort |
  185. Petros A, Bennett D, Vallance P: Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet 338:1557–1558, 1991 | Article | PubMed | ISI | ChemPort |
  186. Fleming I, Gray GA, Julou-Schaeffer G, Parratt JR, Stoclet JC: Incubation with endotoxin activates the L-arginine pathway in vascular tissue. Biochem Biophys Res Commun 171:562–568, 1990 | Article | PubMed | ChemPort |
  187. Hibbs JB Jr, Westenfelder C, Taintor R, Vavrin Z, Kablitz C, Baranowski R, Ward JH, Menlove RL, McMurry MP, Kushner JP: Evidence for cytokine-inducible nitric oxide synthesis from L-arginine in patients receiving interleukin-2 therapy. J Clin Invest 89:867–877, 1992 | PubMed | ISI |
  188. Ochoa JB, Udekwu AO, Billiar TR, Curran RD, Cerra FB, Simmons RL, Peitzman AB: Nitrogen oxide levels in patients following trauma and during sepsis. Ann Surg 214:621–626, 1991 | PubMed | ChemPort |
  189. Giroir BP, Johnson JH, Brown T, Allen GL, Beutler B: The tissue distribution of tumor necrosis factor biosynthesis during endotoxemia. J Clin Invest 90:693–698, 1992 | PubMed | ISI | ChemPort |
  190. Van der Poll T, Buller HR, Ten Cate H, Wortel CH, Bauer KA, Van Deventer SJ, Hack CE, Sauerwein HP, Rosenberg RD, Ten Cate JW: Activation of coagulation after administration of tumor necrosis factor to normal subjects. N Engl J Med 322:1622–1627, 1990 | PubMed | ChemPort |
  191. Durante W, Schini VB, Catovsky S, Kroll MH, Vanhoutte PM, Schafer AI: Plasmin potentiates induction of nitric oxide synthesis by interleukin-1beta in vascular smooth muscle cells. Am J Physiol 264:H617–H624, 1993 | PubMed | ChemPort |
  192. Schini VB, Catovsky S, Durante W, Scott-Burden T, Schafer AI, Vanhoutte PM: Thrombin inhibits induction of nitric oxide synthase in vascular smooth muscle cells. Am J Physiol 264:H611–H616, 1993
  193. Baylis C: Glomerular filtration and volume regulation in gravid animal models, in Baillieres Clinical Obstetrics and Gynecology, edited by MD Lindheimer, JM Davison, London, Bailliere Tindall, 1994
  194. Lindheimer MD, Katz AL: Renal physiology and disease in pregnancy, in The Kidney: Physiology and Pathophysiology, edited by Seldin DW Giebisch G, New York, Raven Press, pp 3371–3432, 1992
  195. Kopp L, Paradiz G, Tucci JR: Urinary excretion of cyclic 3',5'-adenosine monophosphate and cyclic 3',5'-guanosine monophosphate during and after pregnancy. J Clin Endocrinol Metab 44:590–594, 1977
  196. Conrad KP, Vernier KA: Plasma levels, urinary excretion, and metabolic production of cGMP during gestation in rats. AM J Physiol 257:R847–R853, 1989 | PubMed |
  197. Conrad KP, Joffe GM, Kruszyna H, Kruszyna R, Rochelle LG, Smith RP, Chavez JE, Mosher MD: Identification of increased nitric oxide biosynthesis during pregnancy in rats. FASEB J 7:566–571, 1993 | PubMed | ISI | ChemPort |
  198. Engels K, Deng A, Samsell L, Hill C, Bayl15 C: Increased nitric oxide (NO) production in normal pregnancy is resistant to inhibition. (abstract) JASN 4:548A, 1993
  199. Baylis C, Engels K: Adverse interactions between pregnancy and a new model of systemic hypertension produced by chronic blockade of EDRF in rat. Clin Exp Hypertens B11:117–129, 1992
  200. Weiner CP, Lizasoain I, Baylis SA, Knowles RG, Charles IG, Moncada S: Induction of calcium-dependent nitric oxide synthases by sex hormones. Proc Natl Acad Sci USA 91:5212–5216, 1994 | PubMed | ChemPort |
  201. Goetz RM, Morano I, Calovini T, Studer R, Holtz J: Increased expression of endothelial constitutive nitric oxide synthase in rat aorta during pregnancy. Biochem Biophys Res Comm 205:905–910, 1994
  202. Danielson LA, Conrad KP: Nitric oxide mediates renal vasodilation and hyperfiltration during pregnancy in chronically instrumented conscious rats. J Clin Invest (in press)
  203. Conger JD, Falk SA, Guggenheim SJ: Glomerular dynamics and morphologic changes in the generalized Schwartzman reaction in postpartum rats. J Clin Invest 67:1334–1346, 1981
  204. Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK: Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 161:1200–1204, 1989 | PubMed | ISI | ChemPort |
  205. Cook HT, Sullivan R: Glomerular nitrite synthesis in in situ immune complex glomerulonephritis in the rat. Am J Physiol 139:1047–1052, 1991
  206. Cattell V, LaRgen P, De Heer E, Cook T: Glomeruli synthesize nitrite in active Heymann nephritis: The source is infiltrating macrophages. Kidney Int 40:847–851, 1991 | PubMed | ISI | ChemPort |
  207. Cattell V, Lianos E, Largen P, Cook T: Glomerular NO synthase activity in mesangial cell immune injury. Exp Nephrol 1:36–40, 1993 | PubMed | ISI | ChemPort |
  208. Baud L, Oudinet JP, Bens M, Noe L, Peraldi MN, Rondeau E, Etienne J, Ardaillou R: Production of tumor necrosis factor by rat mesangial cells in response to bacterial lipopolysaccharide. Kidney Int 35:1111–1118, 1989 | PubMed | ISI | ChemPort |
  209. Busse R, Mulsch A: Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells. FEBS Lett 275:87–90, 1990 | Article | PubMed | ChemPort |
  210. Weinberg JB, Granger DL, Pisetsky DS, Seldin MF, Misukonis MA, Mason SN, Pippen AM, Ruiz P, Wood ER, Gilkeson GS: The role of nitric oxide in the pathogenesis of spontaneous murine autoimmune disease: Increased nitric oxide production and nitric oxide synthase expression in MRL-lpr/lpr mice, and reduction of spontaneous glomerulonephritis and arthritis by orally administered NG-monomethyl-L-arginine. J Exp Med 179:651–660, 1994 | Article | PubMed | ISI | ChemPort |
  211. Jansen A, Lewis S, Cattell V, Cook HT: Arginase is a major pathway of L-arginine metabolism in nephritic glomeruli. Kidney Int 42:1107–1112, 1992 | PubMed | ISI | ChemPort |
  212. Reyes AA, Porras BH, Chasalow FI, Klahr S: L-arginine decreases the infiltration of the kidney by macrophages in obstructive nephropathy and puromycin-induced nephrosis. Kidney Int 45:1346–1354, 1994 | PubMed | ISI | ChemPort |
  213. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA: Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 87:1620–1624, 1990 | Article | PubMed | ChemPort |
  214. Shah, SV: Role of reactive oxygen metabolites in experimental glomerular disease. Kidney Int 35:1093–1106, 1989 | PubMed | ISI | ChemPort |
  215. Lipton SA, Choi YB, Pan ZN, Lei SZ, Chen HS, Sucher NJ, Loscalzo J, Singel DJ, Stamler JS: A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature 364:626–631 | Article | PubMed | ISI | ChemPort |
  216. Garg U, Hassid A: Inhibition of rat mesangial cell mitogenesis by nitric oxide-generating vasodilators. Am J Physiol 257:F60–F66, 1989 | PubMed | ISI | ChemPort |

Extra navigation

.
ADVERTISEMENT